Warming Contrast Media for Hysterosalpingography

April 19, 2011 updated by: Taizhou Hospital

Comparison of the Warm and Cold Contrast Media for Hysterosalpingography: a Prospective, Randomized Study

The purpose of this study is to compare the use of warm-media with cold-media in performing hysterosalpingography (HSG).

Study Overview

Status

Unknown

Conditions

Detailed Description

As an essential step of the infertile work-up, hysterosalpingography remains widely used in many country since it was first reported at 1914. Although HSG is a non-invasive and safety procedure, it still has some adverse. Lower abdominal pain and vasovagal episodes are mainly acute reactions to the contrast media of HSG, the later include nausea, Vomit, Sweating, Weakness and even bradycardia, occur in 16-54% of patients undergoing HSG.

Many techniques were developed to reduce adverse reactions or alleviate the pain in using of contrast media, include previous analgesia, pretreatment with corticosteroids and using non-ionic contrast media for HSG. However, in a recently Cochrane's review, reported it lack of benefit for using any pain relief medication in HSG.

Pre-Warming the hands and instruments makes physical examination more comfortable for the patients. Local active warming can valid lessen the acute pelvic pain. Experiences from the peritoneal dialysis and the laparoscopy surgical reveal that warm dialysis solution or air insufflation can decrease the pain of operation. A randomize study on Sonohysterography (SHG), another technique for exam tubal and uterine cavity diseases, cue that warming of Echovist contrast media to body temperature is a simple and effective intervention in reducing discomfort at the time exam.Because the less volume of medium injected during the HSG and the iodine medias may have different properties to the Echovist media, whether this intervention is also valid in HSG remains unknown.

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yi-Yang Zhu, MD
  • Phone Number: 86-057-6519-1400
  • Email: yiangz@sohu.com

Study Locations

    • Zhejiang
      • Taizhou City, Zhejiang, China, 317000
        • Recruiting
        • Taizhou Hospital of Zhejiang Province
        • Contact:
        • Principal Investigator:
          • Xianhua Lin
        • Principal Investigator:
          • YingZi Mao
        • Principal Investigator:
          • Qunxi Cai

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 40 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • infertile women who seeking for HSG testing

Exclusion Criteria:

  • suspect of pregnancy
  • acute low reproductive duct infection
  • a known hypersensitivity to iodine
  • genital bleeding
  • genital malignancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: warm media
Subjects undergo HSG using a warm media heated with a 37℃ water-bathing
warm the contrast media with 37℃ water-bathing
Other Names:
  • warm media
NO_INTERVENTION: cold media
the contrast media under room temperature without heat
warm the contrast media with 37℃ water-bathing
Other Names:
  • warm media

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of vasovagal episodes
Time Frame: from the injection of the media to a half hour after HSG
vasovagal episodes include nausea, Vomit, Sweating, Weakness and bradycardia occurred in HSG
from the injection of the media to a half hour after HSG

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analogue scale pain score during HSG
Time Frame: within the first 30 seconds after the constra media "spill out"
assessing the average pain score during HSG,Immediately after the constra media "spill out" the tubal fimbria and spread into periotneum.
within the first 30 seconds after the constra media "spill out"
Visual analogue scale pain score after HSG
Time Frame: a half hour after HSG
10cm Visual analogue scale pain score after HSG
a half hour after HSG

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (ANTICIPATED)

June 1, 2011

Study Completion (ANTICIPATED)

June 1, 2011

Study Registration Dates

First Submitted

April 12, 2011

First Submitted That Met QC Criteria

April 19, 2011

First Posted (ESTIMATE)

April 20, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

April 20, 2011

Last Update Submitted That Met QC Criteria

April 19, 2011

Last Verified

April 1, 2011

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Taizhou200935

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on warming the contrast media

3
Subscribe